Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,420.00
Bid: 1,427.50
Ask: 1,428.00
Change: -21.00 (-1.46%)
Spread: 0.50 (0.035%)
Open: 1,446.50
High: 1,446.50
Low: 1,420.00
Prev. Close: 1,441.00
PSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

9 Jan 2008 07:00

Persimmon PLC09 January 2008 TRADING UPDATE - WEDNESDAY 9 JANUARY 2008 Persimmon plc announces the following trading update ahead of its PreliminaryResults to 31 December 2007, which will be announced on Tuesday 26 February2008. Despite experiencing more challenging trading conditions in the second half of2007, Persimmon expects to announce another strong set of results for the year.We have improved operating margins for the year through a combination of tightcost control, the delivery of further synergy savings from the Westburyacquisition and the benefits emerging from the successful development of ourstrategic land portfolio. This will deliver an increase in profit before tax for2007 in line with the mid range of analyst expectations. The Board confirms that, in line with its previous statement, it recommendspaying a minimum 10% increase in the dividend for the year ended 31 December2007 subject to shareholder approval at the Annual General Meeting in April2008. Since we reported our Interim Results on 21 August 2007, the market has beenmore difficult. Volumes have been impacted as lower consumer confidence and thetightening of credit markets reduced activity in the important Autumn period. Asa result we have achieved 15,905 legal completions during 2007, a reduction of5% against 2006 (16,701). However, sales prices have remained resilient during this period, although asanticipated at the time of our Interim Results, we have experienced an increasein incentives and marketing costs. Underlying price growth of our homes for sale was c. 3% during the year. Theaverage selling price of our homes increased to £189,558 (2006: £188,129). Thisincrease in average selling price has been achieved whilst at the same time wehave increased the proportion of affordable homes developed. During the period we were also increasingly selective with our land purchasesand continued to exercise tight control over our work in progress investment toensure that cash management remained robust. Our total landbank remains at asimilar level to last year and currently we own or control c. 79,000 (2006:80,085) plots for future development. Our balance sheet remains strong and cash flows are healthy, with gearing at theyear end of c. 31% (2006: 33%). Forward sales into 2008 were £603 million (December 2006: £701 million). Thislargely reflects the lower level of sales achieved over the last 3 months of2007 due to market uncertainties. Now that interest rates have changed directionand with the Spring selling period ahead of us we expect to experience anincrease in the level of activity over that achieved in the recent months. Weare operating from c. 7% more outlets than in January 2007 which should furthersupport our sales activity for the Spring season. It is too early in the New Year to predict exactly how the market will developover the next few months. However, we are confident that our focus on cashmanagement through these more challenging times will ensure that when the marketimproves we are well set to take advantage of it. We believe that the underlyingfundamentals for our industry remain intact and supportive. Details of our Results for 2007 and a future market update will be announced onTuesday 26 February 2008. For further information, please contact:Mike Farley, Group Chief ExecutiveMike Killoran, Group Finance Director Persimmon plcOn 9th January 2008: +44 (0) 20 7153 1570After this date: Tel: +44 (0) 1904 642 199 M: CommunicationsEdward Orlebar / Charlotte McMullenTel: +44 (0) 20 7153 1523 / 1549 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Jun 202412:33 pmRNSBlock listing Interim Review
3rd Jun 202411:08 amRNSTotal Voting Rights
23rd May 20247:00 amRNSConfirmation of CFO start date
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company
8th Nov 20237:00 amRNSAppointment of Chief Financial Officer
7th Nov 20237:00 amRNSQ3 Trading Statement
3rd Nov 20231:15 pmRNSHolding(s) in Company
1st Sep 20231:15 pmRNSTotal Voting Rights
10th Aug 20237:04 amRNSHalf Year Results
27th Jul 202310:13 amRNSDirectorate Change
10th Jul 20239:27 amRNSDirector Declaration
3rd Jul 20232:46 pmRNSTotal Voting Rights
1st Jun 20234:38 pmRNSTR-1: Notification of major holdings
1st Jun 20231:07 pmRNSBlock listing Interim Review
1st Jun 202311:06 amRNSTotal Voting Rights
3rd May 20235:00 pmRNSHolding(s) in Company
3rd May 20234:12 pmRNSDirector/PDMR Shareholding
2nd May 202311:13 amRNSTotal Voting Rights
26th Apr 20234:32 pmRNSResult of AGM
26th Apr 20237:00 amRNSQ1 Trading Statement
3rd Apr 20234:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:05 pmRNSTotal Voting Rights
27th Mar 20233:44 pmRNSDirector/PDMR Shareholding
22nd Mar 20233:00 pmRNSAnnual Report 2022 and Notice of AGM 2023
13th Mar 20231:57 pmRNSDirectorate Change
13th Mar 202312:19 pmRNSUK Government Self Remediation Contract Signed
7th Mar 20235:33 pmRNSHolding(s) in Company
7th Mar 20237:04 amRNSDirector Declaration
6th Mar 20235:02 pmRNSHolding(s) in Company
1st Mar 20237:00 amRNSFull Year Results
12th Jan 20237:00 amRNSTrading Statement
1st Dec 20225:30 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20225:25 pmRNSVoting Rights and Capital
8th Nov 20227:00 amRNSTrading Statement
1st Nov 20221:00 pmRNSTotal Voting Rights
1st Nov 20229:24 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.